Skip Navigation

Center for Immunization Research

Left Background

Influenza Selected Publications

Coelingh KL, Luke CJ, Jin H, Talaat KR. Development of live attenuated influenza vaccines against pandemic influenza strains. Vaccines. 2014 July;13(7):855-71 Doi: 10.1586/14760584.2014.922417. PMID: 24867587

Talaat KR, Luke CJ, Khurana S, Manischewitz J, King LR, McMahon BA, Karron RA, Lewis KD, Qin J, Follmann DA, Golding H, Neuzil KM, Subbarao K. A Live Attenuated Influenza A(H5N1) Vaccine Induces Long-Term Immunity in the Absence of a Primary Antibody Response. J Infect Dis. 2014 Jun 15;209(12):1860-9

Talaat KR, Karron RA, Thumar B, McMahon BA, Schmidt AC, Collins PL, Buchholz UJ. Experimental infection of adults with recombinant wild-type human metapneumovirus. J Infect Dis. 2013 Nov 15;208(10):1669-78

Talaat KR, Karron RA, Liang PH, McMahon BA, Luke CJ, Thumar B, Chen GL, Min JY, Lamirande EW, Jin H, Coelingh KL, Kemble GW, Subbarao K. An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.Influenza Other Respi Viruses. 2013 Jan, 7(1):66-73.

Khurana S, Verma N, Talaat KR, Karron RA, Golding H. Immune Response Following H1N1pdm09 Vaccination: Differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender. J Infect Dis . 2012 Feb;205(4):610-20.

Talaat KR, Karron RA, Luke CJ, Thumar B, McMahon BA, Chen GL, Lamirande EW, Jin H, Coelingh KL, Kemble G, Subbarao K. An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults. Vaccine 2011 Apr 12; 29(17) 3144-8. 

Talaat KR, Greenberg ME, Lai MH, Hartel GF, Wichems CH, Rockman S, Jeanfreau RJ, Ghosh MR, Kabongo ML, Gittleson C, Karron RA. A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults. J Infect Dis . 2010 Nov 1;202(9):1327-37.PMID: 20874515

Karron RA, Talaat K, Luke C, Callahan K, Thumar B, Dilorenzo S, McAuliffe J, Schappell E, Suguitan A, Mills K, Chen G, Lamirande E, Coelingh K, Jin H, Murphy BR, Kemble G, Subbarao K. Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults. Vaccine. 2009 Aug 6;27(36):4953-60. Epub 2009 Jun 21.PMID: 19540952

Talaat KR, Karron RA, Callahan KA, Luke CJ, DiLorenzo SC, Chen GL, Lamirande EW, Jin H, Coelingh KL, Murphy BR, Kemble G, Subbarao K. A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. Vaccine. 2009 Jun 8;27(28):3744-53. Epub 2009 Apr 17.PMID: 19464558

Karron RA, Callahan K, Luke C, Thumar B, McAuliffe J, Schappell E, Joseph T, Coelingh K, Jin H, Kemble G, Murphy BR, Subbarao K. A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults.
JInfect Dis 2009 Mar 1;199(5):711-6.PMID: 1910163

Kieny MP, Costa A, Hombach J, Carrasco P, Pervikov Y, Salisbury D, Greco M, Gust I, LaForce M, Franco-Paredes C, Santos JI, D'Hondt E, Rimmelzwaan G, Karron R, Fukuda K. A global pandemic influenza vaccine action plan. Vaccine. 2006 Sep 29; 24(40-41):6367-70.

Karron RA, Steinhoff MC, Subbarao EK, Wilson MH, Macleod K, Clements ML, Fries LF, Murphy BR. Safety and immunogenicity of a cold-adapted influenza A (H1N1) reassortant virus vaccine administered to infants less than six months of age.Pediatr Infect Dis J. 1995 Jan;14(1):10-6.

Faden, RR, Karron, RA. The obligation to prevent the next dual-use controversy. Science  2012 February: online: DOI:10.1126